Followers | 868 |
Posts | 35621 |
Boards Moderated | 16 |
Alias Born | 03/22/2016 |

Monday, January 23, 2023 9:14:04 AM
Recent INBX News
- Inhibrx Biosciences Announces Departure of CSO and Appointments of New CSO and President • PR Newswire (US) • 04/01/2025 08:05:00 PM
- Inhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial Results • PR Newswire (US) • 03/17/2025 08:05:00 PM
- Inhibrx Biosciences Announces Preliminary Data from the Phase 1 Trial of ozekibart (INBRX-109) for the Treatment of Colorectal Cancer • PR Newswire (US) • 01/21/2025 10:01:00 PM
- Inhibrx Biosciences Announces Loan Agreement with Oxford Finance • PR Newswire (US) • 01/13/2025 09:15:00 PM
- Inhibrx Biosciences Reports Third Quarter 2024 Financial Results • PR Newswire (US) • 11/14/2024 09:24:00 PM
- Inhibrx Prevails in Trade Secret Case, Reaffirming Its Commitment to Integrity and Innovation • PR Newswire (US) • 11/04/2024 09:00:00 PM
- Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights • PR Newswire (US) • 08/13/2024 10:54:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/31/2024 08:30:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 10:21:39 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 05/30/2024 08:34:57 PM
- Form POSASR - Post-effective Amendment to an automatic shelf registration statement • Edgar (US Regulatory) • 05/30/2024 08:32:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/30/2024 08:13:37 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/28/2024 08:55:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 10:15:17 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:44:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/24/2024 08:08:28 PM
- Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi • PR Newswire (US) • 05/24/2024 08:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/22/2024 01:54:07 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/21/2024 01:48:48 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 09:29:05 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/17/2024 08:25:28 PM
- Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off • PR Newswire (US) • 05/10/2024 10:36:00 PM
VAYK Corrects Major Clerical Error to Report $668K Operating Revenue for 2024 • VAYK • Apr 17, 2025 9:00 AM
UAV Corp Names David Dugas as President and Chief Operating Officer • UMAV • Apr 17, 2025 8:30 AM
Yuengling's Ice Cream Corporation (OTC: YCRM), Doing Business as ReachOut, Files 2024 10-K With Profitability, Growth, and Corporate Transformation in Focus • YCRM • Apr 16, 2025 11:07 AM
Avant Technologies and JV Partner, Ainnova, Accelerate Expansion Across Latin America Following Key Role at Healthcare Innovation Summit • AVAI • Apr 16, 2025 8:00 AM
HealthLynked Welcomes Anthony Scuilla as Sales Consultant to Drive Strategic Partnerships with Insurance Providers • HLYK • Apr 14, 2025 8:00 AM
Glidelogic Corp. Partners with Sunwah Global Youth Innovation Center • GDLG • Apr 10, 2025 4:00 PM